Insider Transactions Reported by 16 Insiders of HilleVax, Inc.

Location
Boston, MA

There are no Buy or Sell transactions made by insiders since 15 Mar 2025

HilleVax, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Patrick J. Heron Director $16,249,818 23 Jun 2025
David A. Socks CFO & Chief Business Officer $11,920,353 28 Apr 2022
Astrid Borkowski Chief Medical Officer $3,208,660 08 Feb 2024
Sean McLoughlin Chief Operating Officer $21,225 28 Mar 2024
TAKEDA PHARMACEUTICAL CO LTD 10%+ Owner $0 17 Sep 2025
Frazier Life Sciences X, L.P. 10%+ Owner $0 17 Sep 2025
Julie L. Gerberding Director $0 17 Sep 2025
Aditya Kohli Director $0 17 Sep 2025
Shane Maltbie Chief Financial Officer $0 17 Sep 2025
Gary Dubin Director $0 17 Sep 2025
Jeryl L. Hilleman Director $0 17 Sep 2025
Robert Hershberg President and CEO, Director $0 17 Sep 2025
Shelley Chu Director $0 17 Sep 2025
Jaime Sepulveda Director $0 17 Sep 2025
Nanette Cocero Director $0 17 Sep 2025
Susan Michele Silbermann Director 19 Aug 2022

Recent Insider Transactions by Companies or Individuals for HilleVax, Inc.

Showing up to 300 most recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
Takeda Pharmaceutical Co Ltd HLVX Common Stock Disposition pursuant to a tender of shares in a change of control transaction -100% -6,724,000 0 17 Sep 2025 See Explanation of Responses
Frazier Life Sciences X, L.P. HLVX Common Stock Disposition pursuant to a tender of shares in a change of control transaction -100% -17,199 0 17 Sep 2025 By Patrick J. Heron
Frazier Life Sciences X, L.P. HLVX Common Stock Disposition pursuant to a tender of shares in a change of control transaction -100% -8,535,337 0 17 Sep 2025 By Frazier Life Sciences X, L.P.
Robert Hershberg HLVX Common Stock Disposition pursuant to a tender of shares in a change of control transaction -100% -1,101,498 0 17 Sep 2025 Direct
Nanette Cocero HLVX Common Stock Disposition pursuant to a tender of shares in a change of control transaction -100% -17,199 0 17 Sep 2025 Direct
Jeryl L. Hilleman HLVX Common Stock Disposition pursuant to a tender of shares in a change of control transaction -100% -59,224 0 17 Sep 2025 Direct
Shelley Chu HLVX Common Stock Disposition pursuant to a tender of shares in a change of control transaction -100% -17,199 0 17 Sep 2025 Direct
Gary Dubin HLVX Common Stock Disposition pursuant to a tender of shares in a change of control transaction -100% -17,199 0 17 Sep 2025 Direct
Aditya Kohli HLVX Common Stock Disposition pursuant to a tender of shares in a change of control transaction -100% -698,171 0 17 Sep 2025 Direct
Julie L. Gerberding HLVX Common Stock Disposition pursuant to a tender of shares in a change of control transaction -100% -59,224 0 17 Sep 2025 Direct
Jaime Sepulveda HLVX Common Stock Disposition pursuant to a tender of shares in a change of control transaction -100% -59,224 0 17 Sep 2025 Direct
Shane Maltbie HLVX Common Stock Disposition pursuant to a tender of shares in a change of control transaction -100% -83,738 0 17 Sep 2025 Direct
Patrick J. Heron HLVX Common Stock Award 17,199 17,199 23 Jun 2025 Direct
Aditya Kohli HLVX Common Stock Award 2.53% 17,199 698,171 23 Jun 2025 Direct
Shelley Chu HLVX Common Stock Award 17,199 17,199 23 Jun 2025 Direct
Jaime Sepulveda HLVX Common Stock Award 40.9% 17,199 59,224 23 Jun 2025 Direct
Nanette Cocero HLVX Common Stock Award 17,199 17,199 23 Jun 2025 Direct
Julie L. Gerberding HLVX Common Stock Award 40.9% 17,199 59,224 23 Jun 2025 Direct
Gary Dubin HLVX Common Stock Award 17,199 17,199 23 Jun 2025 Direct
Jeryl L. Hilleman HLVX Common Stock Award 40.9% 17,199 59,224 23 Jun 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.